Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism and Pharmacokinetics of BI 764198 in Healthy Male Volunteers
NCT05863130Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of apecotrep (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Mass Balance Recovery of Total Radioactivity in Urine and Faeces at 725 hours. Started May 2023; status: completed.
02
Drugs
apecotrep
Beyond the preview
Go deeper on NCT05863130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863130.